Skip to main content
. 2015 Jun 28;7(12):1685–1693. doi: 10.4254/wjh.v7.i12.1685

Figure 6.

Figure 6

There was no significant difference in cumulative survival rate between the groups, with a median survival time of 121 d in the tolvaptan group and 123 d in the control group.